Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 28, 2024
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATEJohan Blakkisrud, Avery B Peterson, Scott J Wildermann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab SatetraxetanJohan Blakkisrud, Ayca Løndalen, Anne C T Martinsen, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|November 21, 2023
Traceable calibration with 177Lu and comparison of activity meters at hospitals in Norway and SwedenCecilia Hindorf, Lovisa Jessen, Selma Curkic Kapidzic, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2024
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trialsCaroline Stokke, Silvano Gnesin, Johannes Tran-Gia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2026
Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal MetastasesSimen Rykkje Grønningsæter, Johan Blakkisrud, Monika Kvassheim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can 177Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.Blood Advances|September 3, 2020
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphomaArne Kolstad, Tim Illidge, Nils Bolstad, et al.Pageof 2